| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 07/03/2007 | US7238724 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV) |
| 07/03/2007 | US7238684 Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing them |
| 07/03/2007 | US7238683 (Cycloalkyleneiminocarbonyl)-indanyl- or -tetrahydronaphthyl- methylamines, e.g., {(1S)-1-[(1S)-5-(4-Fluorophenyl)-2,3-dihydro-1H-inden-1-yl]-2-[(3S)-3-fluoropyrrolidin-1-yl]-2-oxoethyl}amine hydrochloride; particularly for treating type 2 diabetes |
| 07/03/2007 | CA2219655C Process for the catalytic hydrogenation of aromatic nitro compounds |
| 06/28/2007 | WO2007073407A1 Biaryl substituted nitrogen containing heterocycle inhibitors of lta4h for treating inflammation |
| 06/28/2007 | WO2007072089A1 Mglur5 antagonistic carbamoyl-oxime derivatives |
| 06/28/2007 | WO2007071619A1 Process for cross-linking copolymers using a sulfur-containing co-agent |
| 06/28/2007 | WO2006010118A3 Conformationally constrained smac mimetics and the uses thereof |
| 06/28/2007 | US20070149608 3-(4-Benzyloxyphenyl) propanoic acid derivatives |
| 06/28/2007 | US20070149607 Method for producing pyrrolidine derivative |
| 06/28/2007 | US20070149596 Pyrrole derivatives, their preparation and their therapeutic use |
| 06/28/2007 | US20070149595 Compounds having lysophosphatidic acid receptor antagonism and uses thereof |
| 06/28/2007 | US20070149594 N-methyl-4-{4-[5-(4-chloro-3-trifluoromethylphenylcarbamoyl)-1H-pyrrol-3-yl]-phenoxy}pyridine-2-carboxamide; Raf kinases inhibitors |
| 06/28/2007 | US20070149529 inflammatory and immunoregulatory disorders and diseases, allergic diseases, atopic conditions including allergic rhinitis, dermatitis, conjunctivitis, and asthma, autoimmune pathologies such as rheumatoid arthritis and atherosclerosis |
| 06/28/2007 | US20070149516 to treat cellular proliferative diseases, hyperplasias, solid tumor, cardiac hypertrophy, immune disorders and inflammation; modulators of one or more mitotic kinesins; N-(2-(2-dimethylamino-acetylamino)-1-{4-[8-(1-hydroxy-ethyl)-imidazo[1,2-a]pyridin-2-yl]-benzyl}-ethyl)-3-chloro-4-isopropoxy-benzamide |
| 06/28/2007 | US20070149498 Cancer therapy |
| 06/28/2007 | US20070148680 Detection of disease related genes |
| 06/28/2007 | US20070148652 Reagent for detecting an analyte |
| 06/28/2007 | DE102006047988A1 Salz einer Carbonsäure, welche einen N-substituierten Succinimidthiorest enthält, und nicht vulkanisierte Kautschukzusammensetzung, welche dieses enthält Salt of a carboxylic acid containing an N-substituted Succinimidthiorest, and non-vulcanized rubber composition which contains this |
| 06/28/2007 | CA2634701A1 Biaryl substituted nitrogen containing heterocycle inhibitors of lta4h for treating inflammation |
| 06/27/2007 | EP1800727A1 Process for the treatment of an aqueous mixture comprising a dipolar aprotic compound |
| 06/27/2007 | EP1799639A1 Novel dipeptidyl peptidase iv inhibitors, pharmaceutical compositions containing them, and process for their preparation |
| 06/27/2007 | EP1799637A1 Substituted sulfonamidopropionamides and methods of use |
| 06/27/2007 | EP1689708B1 N-acyl-n -benzyl-alkylendiamino derivatives |
| 06/27/2007 | EP1483238B1 Method for the simultaneous production of tetrahydrofurans and pyrrolidones |
| 06/27/2007 | EP1480955B1 O-cyclopropyl-carboxanilides and their use as fungicides |
| 06/27/2007 | EP1144366B1 3,4-disubstituted acylanilide derivatives and their use as androgen receptor suppressors |
| 06/27/2007 | CN1989100A Therapeutic compounds |
| 06/27/2007 | CN1986545A Folid acid derivatives and their salts for preparing antitumor medicine |
| 06/27/2007 | CN1323073C preparation process of methyl pyrrolidine |
| 06/26/2007 | US7235690 Anthranilamides and methods of their use |
| 06/26/2007 | US7235581 For therapy of Alzheimer's disease |
| 06/26/2007 | US7235580 Mitotic kinesin inhibitors |
| 06/26/2007 | US7235579 Antiinflammatory agents; antidepressants; respiratory system disorders; cognition activators |
| 06/26/2007 | US7235544 for use in conjunction with thrombolytic agents, thus permitting the use of a lower dose of thrombolytic agent; treatment of acute vascular diseases; may have potential in neurogenerative diseases such as Parkinson's and Alzheimer's disease |
| 06/21/2007 | WO2007070760A2 Compounds which modulate the cb2 receptor |
| 06/21/2007 | WO2007070667A2 Crystal form of atorvastatin hemi-calcium and processes for preparation thereof |
| 06/21/2007 | WO2007070556A2 N-(6-membered aromatic ring)-amido anti-viral compounds |
| 06/21/2007 | WO2007069924A1 Deazapurine analogs of 4'-aza-l-nucleosides |
| 06/21/2007 | WO2007069923A1 Deazapurine analogs of 1'-aza-l-nucleosides |
| 06/21/2007 | WO2007047447A3 Diuretic-like compound analogs useful for regulation of central nervous system disorders |
| 06/21/2007 | WO2006124861A3 Benzofuran compounds |
| 06/21/2007 | WO2006115918A3 Vla-4 antagonists |
| 06/21/2007 | US20070142662 Process for the preparation of 7-amino syn 3,5-dihydroxy heptanoic acid derivatives via 6-cyano syn 3,5-dihydroxy hexanoic acid derivatives |
| 06/21/2007 | US20070142648 Hydrogenation method for producing optically active alcohols or carboxylic acids |
| 06/21/2007 | US20070142647 Oxopyrrolidine compounds, preparation of said compounds and their use in the manufacturing of levetiracetam and analogues |
| 06/21/2007 | US20070142455 N-acyl-n'-benzyl-alkylendiamino derivatives |
| 06/21/2007 | US20070142450 Novel urea derivatives and their medical use |
| 06/21/2007 | US20070142445 4-(3,3-Dihalo-Allyloxy) Phenoxy Alkyl Derivatives |
| 06/21/2007 | US20070142432 4-((5-Ethoxy-2-fluoro-3-isopropoxyphenyl)(4-p-tolyl-1H-imidazol-2-yl)methylamino)benzimidazole bis(trifluoroacetic acid salt); leukotriene A4 hydrolase inhibitors; antiinflammatory agents; atherosclerosis; angina pectoris; myocardium infarction; antiischemic aagents; angioplasty; stents; bypass; grafting |
| 06/21/2007 | US20070142393 Sulfonyl-derivatives as novel inhibitors of histone deacetylase |
| 06/21/2007 | US20070142381 Calcium receptor modulating agents |
| 06/21/2007 | US20070142379 Cyclohexyl derivatives as selective estrogen receptor modulators |
| 06/21/2007 | US20070142375 Pyrrolidine derivatives as factor xa inhibitors |
| 06/21/2007 | US20070142374 e.g. 2-(4-Chlorophenyl)-N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}ethenesulfonamide; blood coagulation factor and trypsin-like serine protease inhibitor; anticoagulant, antiinflammatory agent; atherosclerotic plaque, myocardial infarction and unstable angina |
| 06/21/2007 | US20070142353 such as 2-(3-(aminomethyl)pyrrolidin-1-yl)-4-(4-methoxybenzyl)-7-oxo-4,7-dihydro[1,3]thiazolo[4,5-b]pyridine-6-carboxylic acid, used for treating drug-resistant bacterial infections |
| 06/21/2007 | US20070142335 e.g. 2-amino-2-methyl-4-{1-methyl-5-[4-(3,4-dimethylphenyl)butanoyl]pyrrol-2-yl}butan-1-ol ; immunology-related disease selected from crohn's disease ulcerative colitis, multiple sclerosis, atopic dermatitis, insulin dependent diabetes mellitus, glomerular nephritis and rejection of a transplanted organ |
| 06/21/2007 | US20070142301 inhibit HCV NS3/NS4a serine protease activity; modulate the processing of hepatitis C virus (HCV) polypeptide |
| 06/21/2007 | US20070141659 Sets and Compositions Pertaining to Analyte Determination |
| 06/21/2007 | US20070141624 Activity-based probes and methods of their preparation ans use |
| 06/21/2007 | US20070141021 Methylmaleimidyl polymer derivatives |
| 06/21/2007 | CA2633541A1 N-(6-membered aromatic ring)-amido anti-viral compounds |
| 06/21/2007 | CA2633268A1 Crystal form of atorvastatin hemi-calcium and processes for preparation thereof |
| 06/21/2007 | CA2632030A1 Compounds which modulate the cb2 receptor |
| 06/20/2007 | EP1797100A1 Nitrate esters and their use for mitigating cellular damage |
| 06/20/2007 | EP1797094A2 1,3-disubstituted heteroaryl nmda/nr2b antagonists |
| 06/20/2007 | EP1797052A1 Bicyclic compounds which inhibit beta-secretase activity and methods of use thereof |
| 06/20/2007 | EP1797036A1 Sigma receptor ligands |
| 06/20/2007 | EP1796466A2 Antibacterial agents |
| 06/20/2007 | EP1381590B1 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 06/20/2007 | CN1984899A CXCR1 and CXCR2 chemokine antagonists |
| 06/20/2007 | CN1984885A Bicyclic aromatic sulfinyl derivatives |
| 06/20/2007 | CN1984871A Process for preparing nitrooxy esters, nitrooxy thioesters, nitrooxy carbonates and nitrooxy thiocarbonates, intermediates useful in said process and preparation thereof |
| 06/20/2007 | CN1984563A Substituted 1H-pyrrole-2,5-diones |
| 06/20/2007 | CN1982298A Hydro diamine compound, its production and use and composition containing it |
| 06/20/2007 | CN1982296A C2 phenyl-substituted cyclic keto-enols used as pesticides and herbicides |
| 06/20/2007 | CN1982290A Fungicidal carboxamides |
| 06/20/2007 | CN1321996C Process for preparing 2-iminopyrrolidine derivatives |
| 06/20/2007 | CN1321964C Lightfast additive having uv-absorbing moiety and ink composition including the same |
| 06/20/2007 | CN1321682C New dipeptidyl peptidase iv inhibitors and their uses as anti-cancer agents |
| 06/19/2007 | US7232926 Reacting a primary or secondary amine with of SO3 or a source in the presence of a tert-amine and reacting the sulfamate formed with a phosphorus halide; the product may be reacted with NH3 to form the sulfamide, the NH2 group of which may then be acylated with a N-heterocycl-N-ylbenzoyl derivative |
| 06/19/2007 | US7232915 Process for the synthesis of 1,3-diols |
| 06/19/2007 | US7232907 Reacting compounds such as 7-chloro-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid with 4-Aminomethyl-3-methoxyimino-pyrrolidinium dimethanesulfonate in presence of triethylamine or a tetraC1-6alkylammonium hydroxide, and an aqueous solvent |
| 06/19/2007 | US7232821 (2-((2-alkoxy)-phenyl) -cyclopent-1enyl) aromatic carbo and heterocyclic acid and derivatives |
| 06/19/2007 | US7232811 Furosemide modulators of HM74 |
| 06/14/2007 | WO2007066828A1 Process for producing optically active 4-amino-3-substituted phenylbutanoic acid |
| 06/14/2007 | WO2007065634A1 3-carboxy- 2-oxo-1 -pyrrolidine derivatives and their uses |
| 06/14/2007 | WO2007065292A1 Optically pure diamides and the preparation and uses thereof |
| 06/14/2007 | WO2004043335A3 Methods of treating infection by drug resistant bacteria |
| 06/14/2007 | US20070135507 N-1-[(4-chlorophenyl)]-N-2-{[4-(2{dimethylaminomethyl }phenyl)phenyl]-}-(2R,4R)-4-hydroxypyrrolidine-1,2-dicarboxamide; inhibitors of coagulation factor Xa; thromboembolic diseases; tumors |
| 06/14/2007 | US20070135505 Aralkyl ester soft drugs |
| 06/14/2007 | US20070135502 Heterocyclic compounds and methods of use |
| 06/14/2007 | US20070135498 5-Amino-4-hydroxy-2-isopropyl-7-[4-methoxy-3-(3-methoxy-propoxy)-benzyl]-8-methyl-nonanoic acid (1-hydroxymethyl-cyclopentyl)-amide; hypertension, atherosclerosis, unstable coronary syndrome, congestive heart failure, cardiac hypertrophy, cardiac fibrosis, cardiomyopathy postinfarction, alzheimers |
| 06/14/2007 | US20070135494 Substituted 5-aminomethyl-1H-pyrrole-2-carboxylic acid amides |
| 06/14/2007 | US20070135483 Such as 14-O[(N-(3-Methyl-2-amino-buturyl-piperidin-3(S)-yl)sulfanyl)acetyl]mutilin |
| 06/14/2007 | US20070135482 Substituted pyrrolidine and related compounds |
| 06/14/2007 | US20070135475 Process for the preparation of ccr-2 antagonists |
| 06/14/2007 | US20070135446 Benzoylguanidlne salt and hydrates thereof |
| 06/14/2007 | US20070135410 3-Aminopyrrolidone derivatives |
| 06/14/2007 | US20070135392 Apoptosis promoters |